-
Product Insights
NewLikelihood of Approval Analysis for Gram-Positive Bacterial Infections
Overview How likely is it that the drugs in Gram-Positive Bacterial Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gram-Positive Bacterial Infections Overview Gram-positive bacterial infections are caused by bacteria...
-
Product Insights
NewLikelihood of Approval Analysis for Bacteremia
Overview How likely is it that the drugs in Bacteremia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bacteremia Overview Bacteremia is a medical condition characterized by the presence of bacteria...
-
Product Insights
NewLikelihood of Approval Analysis for Duodenal Ulcer
Overview How likely is it that the drugs in Duodenal Ulcer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Duodenal Ulcer Overview Duodenal ulcers, a subset of peptic ulcer disease, result...
-
Product Insights
NewLikelihood of Approval Analysis for Systemic Sclerosis (Scleroderma)
Overview How likely is it that the drugs in Systemic Sclerosis (Scleroderma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Sclerosis (Scleroderma) Overview Scleroderma is a group of rare diseases...
-
Product Insights
NewLikelihood of Approval Analysis for Bacterial Vaginosis
Overview How likely is it that the drugs in Bacterial Vaginosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bacterial Vaginosis Overview Bacterial vaginosis (BV), also known as vaginal bacteriosis, is...
-
Product Insights
NewLikelihood of Approval Analysis for Pertussis (Whooping Cough)
Overview How likely is it that the drugs in Pertussis (Whooping Cough) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pertussis (Whooping Cough) Overview Pertussis, also known as whooping cough, is...
-
Product Insights
NewLikelihood of Approval Analysis for Lyme Disease
Overview How likely is it that the drugs in Lyme Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lyme Disease Overview Lyme disease is a bacterial infection transmitted by a...
-
Product Insights
NewLikelihood of Approval Analysis for Gastric Ulcers
Overview How likely is it that the drugs in Gastric Ulcers will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastric Ulcers Overview Gastric ulcer is a painful sore or ulcer in...
-
Product Insights
NewLikelihood of Approval Analysis for Peptic Ulcers
Overview How likely is it that the drugs in Peptic Ulcers will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peptic Ulcers Overview Peptic ulcers are open sores that develop on the...
-
Product Insights
NewLikelihood of Approval Analysis for Sickle Cell Disease
Overview How likely is it that the drugs in Sickle Cell Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sickle Cell Disease Overview Sickle cell anemia is a genetic (inherited)...